There is no PCOS-specific safety data
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging By calming inflammation and reducing excess fat, semaglutide may postpone several molecular signs of aging, pointing to the potential of GLP1 receptor agonists to help prevent agerelated diseases Date: July 14, 2026 Source: University of California - San Diego Summary: Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging
Obesity as a Chronic Disease.
Nevertheless, GLP1RAs did not statistically significantly improve systolic function, as demonstrated by Kumarathurai et al
Your health and well-being are our foremost concerns
Supplements claiming "GLP-1" effects typically contain ingredients purported to stimulate the body's natural GLP-1 production or mimic its effects